3-191329954-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_178335.3(CCDC50):​c.49+231G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.168 in 138,092 control chromosomes in the GnomAD database, including 2,594 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.17 ( 2594 hom., cov: 22)

Consequence

CCDC50
NM_178335.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.211

Publications

3 publications found
Variant links:
Genes affected
CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
UTS2B (HGNC:30894): (urotensin 2B) Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-191329954-G-A is Benign according to our data. Variant chr3-191329954-G-A is described in ClinVar as [Benign]. Clinvar id is 1286281.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.467 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC50NM_178335.3 linkc.49+231G>A intron_variant Intron 1 of 11 ENST00000392455.9 NP_848018.1 Q8IVM0-2
UTS2BNM_198152.5 linkc.-665+460C>T intron_variant Intron 1 of 8 ENST00000340524.10 NP_937795.2 Q765I0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC50ENST00000392455.9 linkc.49+231G>A intron_variant Intron 1 of 11 1 NM_178335.3 ENSP00000376249.4 Q8IVM0-2
UTS2BENST00000340524.10 linkc.-665+460C>T intron_variant Intron 1 of 8 2 NM_198152.5 ENSP00000340526.5 Q765I0
CCDC50ENST00000392456.4 linkc.49+231G>A intron_variant Intron 1 of 10 1 ENSP00000376250.4 Q8IVM0-1
UTS2BENST00000432514.5 linkc.-832+460C>T intron_variant Intron 1 of 6 5 ENSP00000401028.1 C9JU87

Frequencies

GnomAD3 genomes
AF:
0.168
AC:
23121
AN:
137988
Hom.:
2588
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.174
Gnomad AMI
AF:
0.106
Gnomad AMR
AF:
0.204
Gnomad ASJ
AF:
0.131
Gnomad EAS
AF:
0.485
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.0780
Gnomad MID
AF:
0.190
Gnomad NFE
AF:
0.145
Gnomad OTH
AF:
0.167
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.168
AC:
23143
AN:
138092
Hom.:
2594
Cov.:
22
AF XY:
0.168
AC XY:
11155
AN XY:
66532
show subpopulations
African (AFR)
AF:
0.174
AC:
6467
AN:
37154
American (AMR)
AF:
0.204
AC:
2756
AN:
13490
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
437
AN:
3340
East Asian (EAS)
AF:
0.484
AC:
2094
AN:
4324
South Asian (SAS)
AF:
0.239
AC:
947
AN:
3970
European-Finnish (FIN)
AF:
0.0780
AC:
671
AN:
8608
Middle Eastern (MID)
AF:
0.179
AC:
48
AN:
268
European-Non Finnish (NFE)
AF:
0.145
AC:
9306
AN:
64168
Other (OTH)
AF:
0.170
AC:
326
AN:
1914
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.548
Heterozygous variant carriers
0
639
1278
1916
2555
3194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0581
Hom.:
61

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.7
DANN
Benign
0.89
PhyloP100
-0.21
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115986233; hg19: chr3-191047743; API